TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/9/24 17:15 | 7/9/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Booth Bruce | MA | D | S | -17,347 | 38.21 | 0 | -454 | -39 | 723 | I | |||||||||||||||
6/14/24 18:01 | 6/12/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Booth Bruce | MA | D | S.m | -950 | 35.27 | 0 | -27 | -3 | 802 | I | |||||||||||||||
3/15/24 19:23 | 3/14/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Booth Bruce | MA | D | S.m | -5,133 | 40.25 | 0 | -128 | -14 | 807 | I | |||||||||||||||
3/13/24 19:52 | 3/11/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Booth Bruce | MA | D | S.m | -14,912 | 42.20 | 0 | -353 | -30 | 829 | I | |||||||||||||||
1/13/23 16:53 | 1/11/23 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Booth Bruce | MA | D | S.m | -3,822 | 30.22 | 0 | -126 | -12 | 890 | I | |||||||||||||||
12/16/22 17:05 | 12/14/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Booth Bruce | MA | D | S.m | -11,986 | 31.36 | 0 | -382 | -29 | 918 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |